Axalta Coating Systems is generating stable returns on the same capital employed, not compounding earnings. Underlying trends suggest it may not be a potential multi-bagger. High return seekers may find better opportunities elsewhere.
Axalta Coating Systems is undervalued, suggesting a good time to buy more AXTA stock. The prosperous future outlook isn't fully reflected in the current price. Consider other factors like balance sheet strength before investing.
Investors in Axalta Coating Systems are expecting robust future growth, thus the high P/E ratio. A serious risk of earnings deterioration isn't seen likely and hence, a significant fall in share price seems unlikely.
Axalta Coating Systems' high debt usage to boost its ROE is worrying due to associated risks. Despite a fair ROE, the elevated debt level lacks appeal.
Axalta Coating Systems, with steady ROCE levels, doesn't seem to be reinvesting, indicating it might be past its growth stage. This limited return trend might be why its stock only gained 18% in the last five years, hinting at limited future high growth potential.
Axalta's leadership regards Mary Zappone's appointment positively, citing her broad expertise in critical sectors to the company's growth. Her CEO and chemical engineer experience is anticipated to significantly complement the board's capabilities.
Increased insider investment in Axalta Coating Systems indicates optimism for its future. Despite higher purchase prices, this shows belief in the stock’s value. However, some risks like the 1 warning sign remain.
Optimism in the market for Axalta Coating Systems Ltd is seen with EPS growth and increased share price. The company's positive outlook is boosted by insider investments, but risks remain to be considered before investing.
Upgrades •$バイオジェン(BIIB.US)$: Wells Fargo Upgrades to Overweight from EqualWeight - PT $265 •$コメリカ(CMA.US)$: Baird Upgrades to Neutral from Underperform - PT $85 (from $78) •$デルタ航空(DAL.US)$: UBS Upgrades to Buy from Neutral - PT $53 (from $44) •$H.B.フラー(FUL.US)$: Deutsche Bank Upgrades to Buy from Hold - PT $85 (from $72) •$ギャップ(GPS.US)$: Morgan Stanley Upgrades to EqualWeight from Underweight - PT $14 •$ザイオンズ・バンコープ(ZION.US)$: Baird U...
アクサルタ・コーティング・システムズに関するコメント
コラムToday's pre-market stock movers: TWTR, UPS, HSBC, JBLU and more
• $アバデル・ファーマシューティカルズ(AVDL.US)$ +36.1% (continued volatility)
• $Gamida Cell(GMDA.US)$ +20.57% (announces FDA clearance of investigational IND and removal of clinical hold for GDA-201)
• $Venator Materials(VNTR.US)$ +14.61% (VNTR receives $85 mln settlement from Tronox)
• $オーウェンズ・イリノイ(OI.US)$ +10.9% (earnings report)
• $コーニング(GLW.US)$ +9% (earnings report)
• $アーチ・リソーシズ(ARCH.US)$ +7.2% (earnings report)
• $シャーウィン・ウィリアムズ(SHW.US)$ +6.1% (ea...
コラムTop upgrades and downgrades on 4/18
• $バイオジェン(BIIB.US)$ : Wells Fargo Upgrades to Overweight from EqualWeight - PT $265
• $コメリカ(CMA.US)$ : Baird Upgrades to Neutral from Underperform - PT $85 (from $78)
• $デルタ航空(DAL.US)$ : UBS Upgrades to Buy from Neutral - PT $53 (from $44)
• $H.B.フラー(FUL.US)$ : Deutsche Bank Upgrades to Buy from Hold - PT $85 (from $72)
• $ギャップ(GPS.US)$ : Morgan Stanley Upgrades to EqualWeight from Underweight - PT $14
• $ザイオンズ・バンコープ(ZION.US)$ : Baird U...
まだコメントはありません